Hedgehog Signaling Antagonist GDC-0449 (Vismodegib) Inhibits Pancreatic Cancer Stem Cell Characteristics: Molecular Mechanisms
暂无分享,去创建一个
[1] S. Shankar,et al. Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics , 2012, International journal of cancer.
[2] J. Houghton,et al. Hedgehog signaling drives cellular survival in human colon carcinoma cells. , 2011, Cancer research.
[3] S. Shankar,et al. Resveratrol Inhibits Pancreatic Cancer Stem Cell Characteristics in Human and KrasG12D Transgenic Mice by Inhibiting Pluripotency Maintaining Factors and Epithelial-Mesenchymal Transition , 2011, PloS one.
[4] Jingwu Xie,et al. Clinical implications of hedgehog signaling pathway inhibitors , 2011, Chinese journal of cancer.
[5] Z. Duan,et al. cDNA Microarray Gene Expression Profiling of Hedgehog Signaling Pathway Inhibition in Human Colon Cancer Cells , 2010, PloS one.
[6] R. Toftgård,et al. Hedgehog beyond medulloblastoma and basal cell carcinoma. , 2010, Biochimica et biophysica acta.
[7] Raoul Tibes,et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. , 2009, The New England journal of medicine.
[8] A. Maitra,et al. The hedgehog pathway and pancreatic cancer. , 2009, The New England journal of medicine.
[9] A. Ruiz i Altaba,et al. Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion , 2009, EMBO molecular medicine.
[10] M. Katoh,et al. Integrative genomic analyses on GLI1: positive regulation of GLI1 by Hedgehog-GLI, TGFbeta-Smads, and RTK-PI3K-AKT signals, and negative regulation of GLI1 by Notch-CSL-HES/HEY, and GPCR-Gs-PKA signals. , 2009, International journal of oncology.
[11] David Allard,et al. Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer , 2009, Science.
[12] K. Graham,et al. Multipotent CD15+ cancer stem cells in patched-1-deficient mouse medulloblastoma. , 2009, Cancer research.
[13] F. D. de Sauvage,et al. Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. , 2009, Trends in pharmacological sciences.
[14] H. Nagawa,et al. Plaunotol and geranylgeraniol induce caspase-mediated apoptosis in colon cancer. , 2009, The Journal of surgical research.
[15] C. Dullin,et al. Antitumor effects of a combined 5-aza-2'deoxycytidine and valproic acid treatment on rhabdomyosarcoma and medulloblastoma in Ptch mutant mice. , 2009, Cancer research.
[16] K. Lee,et al. Cathepsin B is a target of Hedgehog signaling in pancreatic cancer. , 2009, Cancer letters.
[17] G. Parmigiani,et al. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.
[18] M. Mullendore,et al. An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer , 2008, Molecular Cancer Therapeutics.
[19] Hua Tian,et al. A paracrine requirement for hedgehog signalling in cancer , 2008, Nature.
[20] Jingwu Xie. Hedgehog signaling pathway: Development of antagonists for cancer therapy , 2008, Current oncology reports.
[21] S. Thiyagarajan,et al. Role of GLI2 transcription factor in growth and tumorigenicity of prostate cells. , 2007, Cancer research.
[22] P. Schultz,et al. A Small‐Molecule Antagonist of the Hedgehog Signaling Pathway , 2007, Chembiochem : a European journal of chemical biology.
[23] K. Anderson,et al. Cilia and developmental signaling. , 2007, Annual review of cell and developmental biology.
[24] M. Lauth,et al. The Hedgehog pathway as a drug target in cancer therapy. , 2007, Current opinion in investigational drugs.
[25] Barbara Stecca,et al. Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways , 2007, Proceedings of the National Academy of Sciences.
[26] Xiaoli Ma,et al. Sonic hedgehog-Gli1 pathway in colorectal adenocarcinomas. , 2007, World journal of gastroenterology.
[27] A. Gerber,et al. The hedgehog regulated oncogenes Gli1 and Gli2 block myoblast differentiation by inhibiting MyoD-mediated transcriptional activation , 2007, Oncogene.
[28] P. Sánchez,et al. HEDGEHOG-GLI1 Signaling Regulates Human Glioma Growth, Cancer Stem Cell Self-Renewal, and Tumorigenicity , 2007, Current Biology.
[29] P. Pasqualetti,et al. Low Correspondence Between K-ras Mutations in Pancreatic Cancer Tissue and Detection of K-ras Mutations in Circulating DNA , 2006, Pancreas.
[30] Maria Kasper,et al. GLI transcription factors: mediators of oncogenic Hedgehog signalling. , 2006, European journal of cancer.
[31] M. Grachtchouk,et al. Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle. , 2005, Genes & development.
[32] M. Kasper,et al. Activation of the BCL2 Promoter in Response to Hedgehog/GLI Signal Transduction Is Predominantly Mediated by GLI2 , 2004, Cancer Research.
[33] M. Datta,et al. Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[34] L. Kopelovich,et al. Immunoprevention of Basal Cell Carcinomas with Recombinant Hedgehog-interacting Protein , 2004, The Journal of experimental medicine.
[35] M. Ascano,et al. Regulation of Hedgehog signaling: a complex story. , 2004, Biochemical pharmacology.
[36] P. Sánchez,et al. Hedgehog--Gli signaling in brain tumors: stem cells and paradevelopmental programs in cancer. , 2004, Cancer letters.
[37] M. Nakafuku,et al. Differential activities of Sonic hedgehog mediated by Gli transcription factors define distinct neuronal subtypes in the dorsal thalamus , 2003, Mechanisms of Development.
[38] M. Wiznerowicz,et al. Conditional Suppression of Cellular Genes: Lentivirus Vector-Mediated Drug-Inducible RNA Interference , 2003, Journal of Virology.
[39] H. Weiner,et al. The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. , 2001, Development.
[40] P. Ingham,et al. Hedgehog signaling in animal development: paradigms and principles. , 2001, Genes & development.
[41] C. Hui,et al. Basal cell carcinomas in mice overexpressing Gli2 in skin , 2000, Nature Genetics.
[42] I. Vořechovský,et al. The patched/hedgehog/smoothened signalling pathway in human breast cancer: no evidence for H133Y SHH, PTCH and SMO mutations. , 1999, European journal of cancer.
[43] D. V. Von Hoff,et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[44] E. Diamandis,et al. Pancreatic cancer. , 2013, Clinical chemistry.
[45] S. Shankar,et al. Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells. , 2011, Frontiers in bioscience.
[46] T. Mantamadiotis,et al. Self-renewal mechanisms in neural cancer stem cells. , 2011, Frontiers in bioscience.
[47] Gerald C. Chu,et al. GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation. , 2009, Genes & development.
[48] A. Ruiz i Altaba. Therapeutic inhibition of Hedgehog-GLI signaling in cancer: epithelial, stromal, or stem cell targets? , 2008, Cancer cell.
[49] A. Ruiz i Altaba,et al. Gli proteins and Hedgehog signaling: development and cancer. , 1999, Trends in genetics : TIG.
[50] A. Warshaw. Implications of peritoneal cytology for staging of early pancreatic cancer. , 1991, American journal of surgery.